PhaseBio Pharmaceuticals
Utility Patent Applications

Last updated:

List of all PhaseBio Pharmaceuticals patents 7 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS External link
Filling date: 6 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: METALLOENZYME INHIBITOR COMPOUNDS External link
Filling date: 6 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: METHODS OF REVERSING TICAGRELOR ACTIVITY External link
Filling date: 6 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: METALLOENZYME INHIBITOR COMPOUNDS External link
Filling date: 6 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: METALLOENZYME INHIBITOR COMPOUNDS External link
Filling date: 6 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE External link
Filling date: 6 Sep 2025 Issue date: 12 Nov 2020

Showing 1 to 7 of 7 patents.